Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 43,500
-750 (-1.69%)
At close: Oct 23, 2026
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 323.46 billion as of October 23, 2026. It is the 19,340th most valuable company in the world and the 590th biggest in South Korea.
Market Cap
323.46B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#590 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 323.46B, an increase of 44.04%. That is a compound annual growth rate of 49.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 323.46B | -17.14% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| i-SENS | 471.60B |
| BioNote | 460.16B |
| T&L Co., Ltd. | 418.39B |
| WON TECH | 366.60B |
| Curexo | 318.94B |
| ToolGen | 294.14B |
| Value Added Technology | 255.20B |
| Vieworks | 251.32B |